Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety, PK, PD, and Antitumor Activity of Vecabrutinib (SNS-062) in B Lymphoid Cancers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03037645
Recruitment Status : Recruiting
First Posted : January 31, 2017
Last Update Posted : April 23, 2019
Sponsor:
Information provided by (Responsible Party):
Sunesis Pharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : December 31, 2020
  Estimated Study Completion Date : June 30, 2021